WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025 ...
News that pharmaceutical company MSD Ireland has acquired the WuXi Vaccines manufacturing facility in Dundalk has been welcomed by Louth TDs Paula Butterly and Erin McGreehan.
Wuxi Biologics (Cayman) ( (HK:2269) ) has provided an announcement.
MSD has expanded its presence in Ireland with an agreement to buy a vaccines manufacturing facility from WuXi Biologics in Dundalk. Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm ...